Scintigraphy Study to Evaluate the Gastrointestinal Behavior of EDP1815 Oral Dosage Forms
Clinical trial NCT05066373 · COMPLETED
Trial details
- NCT number
- NCT05066373
- Sponsor
- Evelo Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-09
- Primary completion
- 2022-08-11
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.